Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bader

Showing results (121-130 of 388) with videos related to

Pageof 39
Sort By:
Congenital Heart Disease|October 10, 2013
Evaluation of risk factors for prediction of outcome in fetal spectrum of atrioventricular septal defectsRima S Bader, Rajesh Punn, Norman H Silverman
Blood|February 23, 2021
STING and transplantation: can targeting this pathway improve outcomes?Cameron S Bader, Lei Jin, Robert B Levy
The Quality Letter for Healthcare Leaders|September 5, 1993
System profile. UniHealth America, Burbank, CaliforniaB S Bader, J C Arvantes, R Veatch
Postgraduate Medicine|October 8, 2016
An update on the management of urinary tract infections in the era of antimicrobial resistanceMazen S Bader, Mark Loeb, Annie A Brooks
Plos Computational Biology|November 28, 2007
Where have all the interactions gone? Estimating the coverage of two-hybrid protein interaction mapsHailiang Huang, Bruno M Jedynak, Joel S Bader
Harvard Review of Psychiatry|January 9, 2020
Technology in the Assessment, Treatment, and Management of DepressionCaroline S Bader, Miranda Skurla, Ipsit V Vahia
Blood|December 1, 1995
Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host diseaseK R Schultz, S Bader, J Paquet, et al.
Annals of Neurology|March 1, 1997
Lack of association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron diseaseR Bachus, S Bader, R Gessner, et al.
Clinical Medicine Insights. Oncology|August 13, 2011
Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromideS Bader, K Jaroslawski, H E Blum, et al.
Cutis|April 6, 1999
Multinucleate-cell angiohistiocytoma occurring in a patient with mycosis fungoidesR S Bader, G H Telang, E C Vonderheid
Pageof 39

Showing results (121-130 of 388) with videos related to

Sort By:
Pageof 39
Congenital Heart Disease|October 10, 2013
Evaluation of risk factors for prediction of outcome in fetal spectrum of atrioventricular septal defectsRima S Bader, Rajesh Punn, Norman H Silverman
Blood|February 23, 2021
STING and transplantation: can targeting this pathway improve outcomes?Cameron S Bader, Lei Jin, Robert B Levy
The Quality Letter for Healthcare Leaders|September 5, 1993
System profile. UniHealth America, Burbank, CaliforniaB S Bader, J C Arvantes, R Veatch
Postgraduate Medicine|October 8, 2016
An update on the management of urinary tract infections in the era of antimicrobial resistanceMazen S Bader, Mark Loeb, Annie A Brooks
Plos Computational Biology|November 28, 2007
Where have all the interactions gone? Estimating the coverage of two-hybrid protein interaction mapsHailiang Huang, Bruno M Jedynak, Joel S Bader
Harvard Review of Psychiatry|January 9, 2020
Technology in the Assessment, Treatment, and Management of DepressionCaroline S Bader, Miranda Skurla, Ipsit V Vahia
Blood|December 1, 1995
Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host diseaseK R Schultz, S Bader, J Paquet, et al.
Annals of Neurology|March 1, 1997
Lack of association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron diseaseR Bachus, S Bader, R Gessner, et al.
Clinical Medicine Insights. Oncology|August 13, 2011
Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromideS Bader, K Jaroslawski, H E Blum, et al.
Cutis|April 6, 1999
Multinucleate-cell angiohistiocytoma occurring in a patient with mycosis fungoidesR S Bader, G H Telang, E C Vonderheid
Pageof 39